Collaboration expands CRISPR Therapeutics’ efforts in immuno-oncology.
Read more
CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies
Posted in biotech/medical